IPO - WORK Medical Technology Group LTD

Form Type: 424B4

Filing Date: 2025-05-22

Corporate Action: Ipo

Type: New

Accession Number: 000121390025046583

Filing Summary: WORK Medical Technology Group LTD is offering 10,000,000 Ordinary Units, each consisting of one Class A Ordinary Share, one Series A Warrant, and one Series B Warrant, with a proposed public offering price of $0.50 per Ordinary Unit. Additionally, the company may issue up to 10,000,000 Pre-Funded Ordinary Units in case certain ownership thresholds are exceeded, designed to not trigger beneficial ownership limitations. The Class A Warrants have an exercise price of $1.00 and a term of one year, while the Series B Warrants have a three-month term and an initial exercise price of $1.00. The offering comes as part of a broader capital structure adjustment following a recent increase in authorized share capital and various amendments to the company's articles of association. The company had previously completed its IPO in August 2024, raising over $8 million. The document also discusses potential regulatory risks related to operating in China and being subject to changing regulations regarding overseas offerings. The Class A Ordinary Shares are traded on the Nasdaq under the ticker symbol 'WOK'.

Form Type: F-1/A

Filing Date: 2025-04-09

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025030225

Filing Summary: On April 9, 2025, WORK Medical Technology Group LTD filed Amendment No. 1 to Form F-1 registration statement with the SEC to facilitate their initial public offering (IPO). The company plans to offer 10,000,000 ordinary units, each consisting of one Class A Ordinary Share along with Series A and B Warrants to purchase additional Class A Ordinary Shares. The offering price for the ordinary units is set at $0.50 per unit. The document outlines the terms of the securities being offered, including the terms on the warrants that can be exercised for Class A Ordinary Shares under certain conditions. The company reorganized its share capital following resolutions passed at its annual general meeting, increasing authorized share capital significantly while reclassifying shares into Class A and Class B categories with differential voting rights. This offering is being conducted under the emerging growth company provisions and takes into account regulatory requirements as set forth by U.S. and Chinese regulations regarding overseas listings. The Class A Ordinary Shares are set to be traded on the Nasdaq Capital Market under the symbol 'WOK,' following the completion of the IPO process.

Form Type: 20-F

Filing Date: 2025-02-14

Corporate Action: Ipo

Type: New

Accession Number: 000121390025014076

Filing Summary: WORK Medical Technology Group LTD is providing its annual report for the fiscal year ending September 30, 2024. The company is incorporated in the Cayman Islands and operates through various subsidiaries in the People's Republic of China (PRC). The report includes its audited consolidated financial statements and outlines operational structures, regulatory risks related to PRC laws, and changes in regulatory frameworks that may impact its future operations. It details the company's IPO on the Nasdaq Capital Market, which commenced trading on August 23, 2024, and completed on August 26, 2024. The document elaborates on potential risks concerning Chinese regulations and the company’s compliance structure. It emphasizes that the company conducts operations through its subsidiaries and investors therefore do not own direct stakes in these subsidiaries. The report brings attention to specific risks associated with China’s regulatory environment as well as the regulatory actions that the PRC government could implement, which may affect the valuation of the company’s ordinary shares.

Form Type: F-1

Filing Date: 2024-12-23

Corporate Action: Ipo

Type: New

Accession Number: 000121390024111388

Filing Summary: WORK Medical Technology Group LTD has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission on December 20, 2024, to offer up to 2,500,000 Ordinary Units which include one Ordinary Share, one Series A Warrant, and one Series B Warrant, with an assumed public offering price of $6.00 per Ordinary Unit. Additionally, up to 2,500,000 Pre-Funded Ordinary Units may be offered, each consisting of one Pre-Funded Warrant and similar warrants. The Ordinary Shares began trading on August 23, 2024, following an initial public offering that raised $8,367,768. The company is classified as an emerging growth company and a foreign private issuer. It emphasizes the legal and operational risks associated with conducting operations through its PRC subsidiaries and the implications of regulations from the Chinese government affecting overseas listings. The registration aims to comply with ongoing regulations and to ensure the offering is not seen as violating any laws.